{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:55:36Z","timestamp":1758815736232},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T00:00:00Z","timestamp":1480032000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/pr.2016.258","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T17:02:21Z","timestamp":1480093341000},"page":"531-536","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Phytanic acid attenuates insulin-like growth factor-1 activity via nitric oxide-mediated \u03b3-secretase activation in rat aortic smooth muscle cells: possible implications for pathogenesis of infantile Refsum disease"],"prefix":"10.1038","volume":"81","author":[{"given":"Gursev S.","family":"Dhaunsi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayra","family":"Alsaeid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saghir","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,25]]},"reference":[{"issue":"Pt 5","key":"BFpr2016258_CR1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1042\/BST0350881","volume":"35","author":"AS Wierzbicki","year":"2007","unstructured":"Wierzbicki AS. Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review. Biochem Soc Trans 2007;35(Pt 5):881\u20136.","journal-title":"Biochem Soc Trans"},{"key":"BFpr2016258_CR2","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1194\/jlr.R005959","volume":"51","author":"PP Van Veldhoven","year":"2010","unstructured":"Van Veldhoven PP. Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J Lipid Res 2010;51:2863\u201395.","journal-title":"J Lipid Res"},{"key":"BFpr2016258_CR3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ejhg.2008.252","volume":"17","author":"C Krause","year":"2009","unstructured":"Krause C, Rosewich H, G\u00e4rtner J. Rational diagnostic strategy for Zellweger syndrome spectrum patients. Eur J Hum Genet 2009;17:741\u20138.","journal-title":"Eur J Hum Genet"},{"key":"BFpr2016258_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/ajmg.a.20664","volume":"126A","author":"BT Poll-The","year":"2004","unstructured":"Poll-The BT, Gootjes J, Duran M, et al. Peroxisome biogenesis disorders with prolonged survival: phenotypic expression in a cohort of 31 patients. Am J Med Genet A 2004;126A:333\u20138.","journal-title":"Am J Med Genet A"},{"key":"BFpr2016258_CR5","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/jnen\/60.11.1021","volume":"60","author":"RJ Wanders","year":"2001","unstructured":"Wanders RJ, Jansen GA, Skjeldal OH. Refsum disease, peroxisomes and phytanic acid oxidation: a review. J Neuropathol Exp Neurol 2001;60:1021\u201331.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFpr2016258_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF01799455","volume":"9","author":"BT Poll-The","year":"1986","unstructured":"Poll-The BT, Saudubray JM, Ogier H, et al. Infantile Refsum\u2019s disease: biochemical findings suggesting multiple peroxisomal dysfunction. J Inherit Metab Dis 1986;9:169\u201374.","journal-title":"J Inherit Metab Dis"},{"key":"BFpr2016258_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF01799998","volume":"5","author":"JM Scotto","year":"1982","unstructured":"Scotto JM, Hadchouel M, Odievre M, et al. Infantile phytanic acid storage disease, a possible variant of Refsum\u2019s disease: three cases, including ultrastructural studies of the liver. J Inherit Metab Dis 1982;5:83\u201390.","journal-title":"J Inherit Metab Dis"},{"key":"BFpr2016258_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0022-3476(86)80765-X","volume":"108","author":"SS Budden","year":"1986","unstructured":"Budden SS, Kennaway NG, Buist NR, Poulos A, Weleber RG. Dysmorphic syndrome with phytanic acid oxidase deficiency, abnormal very long chain fatty acids, and pipecolic acidemia: studies in four children. J Pediatr 1986;108:33\u20139.","journal-title":"J Pediatr"},{"key":"BFpr2016258_CR9","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1007\/s00018-005-5463-y","volume":"63","author":"DM van den Brink","year":"2006","unstructured":"van den Brink DM, Wanders RJ. Phytanic acid: production from phytol, its breakdown and role in human disease. Cell Mol Life Sci 2006;63:1752\u201365.","journal-title":"Cell Mol Life Sci"},{"key":"BFpr2016258_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.bbalip.2011.06.006","volume":"1811","author":"RJ Wanders","year":"2011","unstructured":"Wanders RJ, Komen J, Ferdinandusse S. Phytanic acid metabolism in health and disease. Biochim Biophys Acta 2011;1811:498\u2013507.","journal-title":"Biochim Biophys Acta"},{"key":"BFpr2016258_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1749-6632.2009.05254.x","volume":"1190","author":"LI Hellgren","year":"2010","unstructured":"Hellgren LI. Phytanic acid\u2013an overlooked bioactive fatty acid in dairy fat? Ann N Y Acad Sci 2010;1190:42\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"BFpr2016258_CR12","doi-asserted-by":"publisher","first-page":"49319","DOI":"10.1074\/jbc.M204639200","volume":"277","author":"S Idel","year":"2002","unstructured":"Idel S, Ellinghaus P, Wolfrum C, et al. Branched chain fatty acids induce nitric oxide-dependent apoptosis in vascular smooth muscle cells. J Biol Chem 2002;277:49319\u201325.","journal-title":"J Biol Chem"},{"key":"BFpr2016258_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1023\/A:1005376600257","volume":"21","author":"GS Dhaunsi","year":"1998","unstructured":"Dhaunsi GS, Rahbeeni Z, al-Essa M, Ozand PT. Impaired DNA synthesis in dermal fibroblasts from Zellweger syndrome patients. J Inherit Metab Dis 1998;21:179\u201380.","journal-title":"J Inherit Metab Dis"},{"key":"BFpr2016258_CR14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJM199702273360907","volume":"336","author":"D Le Roith","year":"1997","unstructured":"Le Roith D. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med 1997;336:633\u201340.","journal-title":"N Engl J Med"},{"key":"BFpr2016258_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0889-8529(05)70342-X","volume":"25","author":"PF Collett-Solberg","year":"1996","unstructured":"Collett-Solberg PF, Cohen P. The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin North Am 1996;25:591\u2013614.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"BFpr2016258_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-3-540-78281-0_7","volume":"180","author":"C Hellberg","year":"2010","unstructured":"Hellberg C, Ostman A, Heldin CH. PDGF and vessel maturation. Recent Results Cancer Res 2010;180:103\u201314.","journal-title":"Recent Results Cancer Res"},{"key":"BFpr2016258_CR17","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1161\/ATVBAHA.108.166454","volume":"28","author":"RJ Tomanek","year":"2008","unstructured":"Tomanek RJ, Hansen HK, Christensen LP. Temporally expressed PDGF and FGF-2 regulate embryonic coronary artery formation and growth. Arterioscler Thromb Vasc Biol 2008;28:1237\u201343.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFpr2016258_CR18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0008-6363(95)00163-8","volume":"30","author":"P Delafontaine","year":"1995","unstructured":"Delafontaine P. Insulin-like growth factor I and its binding proteins in the cardiovascular system. Cardiovasc Res 1995;30:825\u201334.","journal-title":"Cardiovasc Res"},{"key":"BFpr2016258_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0014-4827(83)90001-0","volume":"145","author":"J Nilsson","year":"1983","unstructured":"Nilsson J, Ksiazek T, Heldin CH, Thyberg J. Demonstration of stimulatory effects of platelet-derived growth factor on cultivated rat arterial smooth muscle cells. Differences between cells from young and adult animals. Exp Cell Res 1983;145:231\u20137.","journal-title":"Exp Cell Res"},{"key":"BFpr2016258_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","volume":"103","author":"J Schlessinger","year":"2000","unstructured":"Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000;103:211\u201325.","journal-title":"Cell"},{"key":"BFpr2016258_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2174\/138161207780249146","volume":"13","author":"L Laviola","year":"2007","unstructured":"Laviola L, Natalicchio A, Giorgino F. The IGF-I signaling pathway. Curr Pharm Des 2007;13:663\u20139.","journal-title":"Curr Pharm Des"},{"key":"BFpr2016258_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0008-6363(95)00148-4","volume":"31","author":"GS Dhaunsi","year":"1996","unstructured":"Dhaunsi GS, Hassid A. Atrial and C-type natriuretic peptides amplify growth factor activity in primary aortic smooth muscle cells. Cardiovasc Res 1996;31:37\u201347.","journal-title":"Cardiovasc Res"},{"key":"BFpr2016258_CR23","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1111\/acer.12875","volume":"39","author":"E Hatch","year":"2015","unstructured":"Hatch E, Morrow D, Liu W, Cahill PA, Redmond EM. Ethanol inhibits \u03b3-secretase proteolytic activity in vascular smooth muscle cells. Alcohol Clin Exp Res 2015;39:2115\u201322.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFpr2016258_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0955-2863(02)00294-2","volume":"14","author":"JJ Moreno","year":"2003","unstructured":"Moreno JJ, Mitjavila MT. The degree of unsaturation of dietary fatty acids and the development of atherosclerosis (review). J Nutr Biochem 2003;14:182\u201395.","journal-title":"J Nutr Biochem"},{"key":"BFpr2016258_CR25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1254\/jphs.92.308","volume":"92","author":"M Hirafuji","year":"2003","unstructured":"Hirafuji M, Machida T, Hamaue N, Minami M. Cardiovascular protective effects of n-3 polyunsaturated fatty acids with special emphasis on docosahexaenoic acid. J Pharmacol Sci 2003;92:308\u201316.","journal-title":"J Pharmacol Sci"},{"issue":"1 Pt 2","key":"BFpr2016258_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1161\/01.HYP.35.1.287","volume":"35","author":"QN Diep","year":"2000","unstructured":"Diep QN, Intengan HD, Schiffrin EL. Endothelin-1 attenuates omega3 fatty acid-induced apoptosis by inhibition of caspase 3. Hypertension 2000;35(1 Pt 2):287\u201391.","journal-title":"Hypertension"},{"key":"BFpr2016258_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11906-001-0021-y","volume":"3","author":"BM Egan","year":"2001","unstructured":"Egan BM, Greene EL, Goodfriend TL. Nonesterified fatty acids in blood pressure control and cardiovascular complications. Curr Hypertens Rep 2001;3:107\u201316.","journal-title":"Curr Hypertens Rep"},{"key":"BFpr2016258_CR28","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bjp.0704768","volume":"136","author":"M Hirafuji","year":"2002","unstructured":"Hirafuji M, Machida T, Tsunoda M, Miyamoto A, Minami M. Docosahexaenoic acid potentiates interleukin-1beta induction of nitric oxide synthase through mechanism involving p44\/42 MAPK activation in rat vascular smooth muscle cells. Br J Pharmacol 2002;136:613\u20139.","journal-title":"Br J Pharmacol"},{"key":"BFpr2016258_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mam.2004.09.003","volume":"26","author":"KM Naseem","year":"2005","unstructured":"Naseem KM. The role of nitric oxide in cardiovascular diseases. Mol Aspects Med 2005;26:33\u201365.","journal-title":"Mol Aspects Med"},{"key":"BFpr2016258_CR30","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.freeradbiomed.2007.12.025","volume":"44","author":"R Ginnan","year":"2008","unstructured":"Ginnan R, Guikema BJ, Halligan KE, Singer HA, Jourd\u2019heuil D. Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases. Free Radic Biol Med 2008;44:1232\u201345.","journal-title":"Free Radic Biol Med"},{"key":"BFpr2016258_CR31","doi-asserted-by":"publisher","first-page":"C824","DOI":"10.1152\/ajpcell.00592.2005","volume":"292","author":"BS Zuckerbraun","year":"2007","unstructured":"Zuckerbraun BS, Stoyanovsky DA, Sengupta R, et al. Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA. Am J Physiol Cell Physiol 2007;292:C824\u201331.","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFpr2016258_CR32","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.bbrc.2007.05.062","volume":"358","author":"B McElroy","year":"2007","unstructured":"McElroy B, Powell JC, McCarthy JV. The insulin-like growth factor 1 (IGF-1) receptor is a substrate for gamma-secretase-mediated intramembrane proteolysis. Biochem Biophys Res Commun 2007;358:1136\u201341.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFpr2016258_CR33","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1751-7176.2008.06632.x","volume":"10","author":"K Bian","year":"2008","unstructured":"Bian K, Doursout MF, Murad F. Vascular system: role of nitric oxide in cardiovascular diseases. J Clin Hypertens (Greenwich) 2008;10:304\u201310.","journal-title":"J Clin Hypertens (Greenwich)"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2016258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2016258","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2016258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:01:39Z","timestamp":1684616499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2016258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,25]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFpr2016258"],"URL":"https:\/\/doi.org\/10.1038\/pr.2016.258","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,25]]},"assertion":[{"value":"31 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}